FTO and Strategies for Biotech Companies
Biotech freedom to operate (FTO) issues are common; resolution can be complicated and have a protracted timeline. FTO risk will be assessed by a suitor during diligence. Significant issues could impact their estimate of product value. So what can a biotech do early on? Consider engaging patent counsel to develop a smart, balanced cost:benefit approach. […]
FTO and Strategies for Biotech Companies Read More »